This announcement is a separate document:
騰盛博藥-B：(1)建議終止現有購股權計劃並採納2023年購股權計劃；(2)建議終止現有股份獎勵計劃並採納2023年股份獎勵計劃；及(3)股東特別大會通告
BRII-B: (1) PROPOSALS FOR TERMINATION OF THE EXISTING SHARE OPTION SCHEME AND ADOPTION OF THE 2023 SHARE OPTION SCHEME; (2) PROPOSALS FOR TERMINATION OF THE EXISTING SHARE AWARD SCHEME AND ADOPTION OF THE 2023 SHARE AWARD SCHEME; AND (3) NOTICE OF EXTRAORD
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.